2025(01)LCX0025(AAR)

AAR-MAHARASHTRA

Roche Diabetes Care India Private Limited

decided on 02-01-2025

CUSTOMS AUTHORITY FOR ADVANCE RU

CUSTOMS AUTHORITY FOR ADVANCE RULINGS
NEW CUSTOM HOUSE, BALLARD ESTATE, MUMBAI - 400 001
E-MAIL: cus-advrulings.mum@gov.in

The 02nd January, 2025
Ruling Nos. CAAR/Mum/ARC/191/2024
in
Application No. CAAR/CUS/APPL/123/2024-O/o Commr-CAAR-MUMBAI
Name and address of the applicant: M/s Roche Diabetes Care India Pvt. Ltd
146-B, 166A, Unit No. 7, 8, 9, 8th floor,
R City Office, R City Mall, LBS Marg,
Ghatkopar Mumbai 400 086
Commissioner concerned: The Principal Commissioner of Customs.
Air Cargo, New Custom House,
Chennai-VII Commissionerate,
Air Cargo Complex, Meenambakkam,
Chennai 600 027.
Present for the applicant: Shri V.S. Chauhan, Ms Apurva Sheth,
Shri Deepak Sawant,
Ms Ruchita Parsarampuria
Present for the Department: None

Ruling

M/s Roche Diabetes Care India Private Limited (hereinafter referred as 'Applicant" or "Roche DC" or "Company" or "We") filed an application for advance ruling before the Customs Authority for Advance Rulings, Mumbai (CAAR, in short). The said application was received in the secretariat of the CAAR, Mumbai on 13.09.2024, along with its enclosures in terms of Section 28H (1) of the Customs Act, 1962 (hereinafter referred to as the Act'). The applicant is seeking clarity and certainty on the following questions via the present advance ruling application --

1. Whether the "Accu-Chek" blood glucose monitoring systems (commonly referred to as "Glucometer") imported by the Applicant is classifiable under Customs Tariff Heading (`CTH') 9027 of Chapter 90 of the First Schedule to the Customs Tariff Act, 1975 (`Customs Tariff Act')?

2. If the answer to the above question is affirmative, whether the Glucometer is classifiable under the Tariff Item 9027 89 90 under CTH 9027 of Chapter 90 of the First Schedule to the Customs Tariff Act?

3. If the answer to the above question is positive, then whether the effective rate of duty will be "Nil" as per the Customs Tariff entry?

4. If the answer to the above questions is negative, then what would be the correct classification of Glucometer under the Customs Tariff Act?

2. Submission by the Applicant:

2.1 The Applicant is a Healthcare Diagnostics Company registered as a "Private Limited Com any" under the Companies Act, 2013 (Corporate Identification Number - U74120MH2015FTC268671) and incorporated in India having its registered office at 8th Floor, 146-B, 166A, Unit No.7,8,9, R City Offices, R City Mall, LBS Marg, Ghatkopar- west, Mumbai - 400086, Maharashtra and is engaged in the business of importing and supplying products pertaining to diabetes management under its popular brand "Accu-Chek"' such as, inter alia, blood glucose monitoring systems (referred to as `Glucometer in common parlance), lancing devices, lancets, strips, etc. The present application has been filed by the applicant seeking clarification in relation to the classification of the product "Accu-Chek" blood glucose monitoring systems (commonly referred to as "Glucometer"). The applicant has made the following submission along with the application dated 13.09.2024 and additional submissions dated 27.11 024.

2.2 The applicant presently imports "Accu-Chek" Glucometers (either as a single product or in kits) from overseas suppliers as follows:

- Accu-Chek Guide Glucometer Kit - this is imported as a kit (Glucometer, lancet, lancing device, carry case and user manuals together) from Roche Diagnostics International AG ("Roche AG")

- Accu-Chek Instant-S Set & Accu-Chek Instant Glucometer Kit -Glucometers, Lancet & Lancing devices are imported from Roche Diagnostics International AG ("Roche AG"). These items along with carry case, user manuals etc. locally procured are converted into kits in the Diabetes care manufacturing facility at Bhiwandi.

- Accu-Chek Active Glucometer Kit - Glucometers are imported from the supplier Sanmina-SCI India Private Limited, located at Oragadam Hi-Tech Special Economic Zone, Kancheepuram, TamilNadu. Lancet & Lancing devices are imported from Roche Diabetes Care Mannheim.

These items along with carry case, user manuals etc. locally procured are converted into kits in the Diabetes care manufacturing facility at Bhiwandi.

    The products are imported as follows:

a. In the state of Tamil Nadu in Free Trade Warehousing Zone ("FTVVZ") and subsequently cleared for home consumption by discharging the applicable customs duties

b. In the state of Maharashtra at Mumbai - Customs Air Cargo wherein the goods are cleared by discharging applicable custom duties.

2.3 Product details:

Glucometer is a portable medical device used to measure the amount of glucose in the blood sample obtained through a finger prick and applied subsequently on the testing strip. The test strips are impregnated with a glucose-specific enzyme that reacts to the blood sample. Using .the electrochemical technology, the device reads the strip to measure the amount of glucose.

Primarily, the Glucometers are designed to allow measuring of blood sugar levels by the patients themselves i.e., there is no requirement of any professional assistance by a physician or a doctor or a paramedic for using the said Glucometer.

In other words, Glucometers, in vast majority of the cases are used by the individuals at home i.e., by the common untrained persons, who are not professional medical or paramedic practitioners.

The said product is supplied by the Company in a kit consisting of a Glucometer, lancet, lancing device, carry case and user manuals together.

The Company supplies the aforesaid kit under its popular brand "Accu-Chek" and is categorized into different models as follows:

- The Accu-Chek Instant--S Set.
- Accu-Chek Active Glucometer Kit.
- Accu-Chek Instant Glucometer Kit.
- Accu-Chek Guide Glucometer Kit.

It is pertinent note that although there are different models of Accu-Chek glucometers, the essential function of these glucometers remains the same i.e., to measure the glucose level in the blood sample through a chemical process. We would like to re-iterate that these Glucometers are designed to allow measuring of blood sugar levels by the patients without requirement of a professional assistance.  

2.4 Presently, the Company imports "Accu-Chek" Glucometers (either as a single product or in kits) from overseas suppliers as follows:

    Accu-Chek Guide Glucometer Kit - this is imported as a kit (Glucometer, lancet, lancing device, carry case and user manuals together) from Roche Diagnostics International AG ("Roche AG")

   Accu-Chek Instant-S Set & Accu-Chek Instant Glucometer Kit -Glucometers, Lancet & Lancing devices are imported from Roche Diagnostics International AG ("Roche AG"). These items along with carry case, user manuals etc. locally procured are converted into kits in the Diabetes care manufacturing facility at Bhiwandi.

    Accu-Ohek Active Glucometer Kit- Glucometers are imported from the supplier Sanmina-SCI India Private Limited, located at Oragadam Hi-Tech Special Economic Zone, Kancheepuram, TamilNadu. Lancet & Lancing devices are imported from Roche Diabetes Care Mannheim.

These items along with carry case, user manuals etc. locally procured are converted into kits in the Diabetes care manufacturing facility at Bhiwandi.

2.5 The pr ducts are imported as follows:

In the state of Tamil Nadu in Free Trade Warehousing Zone ("FTWZ") and subsequently cleared for home consumption by discharging the applicable customs duties

In the state if Maharashtra at Mumbai - Customs Air Cargo wherein the goods are cleared by discharging applicable custom duties.

2.6 The Company has been importing "Accu-Check" Glucometer under the following Customs Tariff Heading along with payment of Basic Custom Duty ("BCD") and IGST at the rates specified below:

Sr. No. Product Type Tariff heading
BCD Rate
Health Cess GST Rate
1 Glucometer 90189099 5% 5% 12%

2.7 It is submitted that the Company was initially classifying the "Accu-Chek" Glucometer under CTH 9027. However, Customs Audit Commissionerate, Mumbai had conducted a customs audit of the records of the Company and directed us to re-classify the Glucometers under CTH 9018. The Company was not convinced with the directives of the Audit Commissionerate. However, it preferred not to contest the said direction. Accordingly, the Company has started classifying the Glucometers under CTH 9018 since 27 July 2017. The Customs authorities also issued a consultation letter dated 24 December 2019 seeking the differential duty for the period prior to reclassification i.e., 27 July 2017. The Company has paid the differential duty along with interest.

2.8 Subsequently, the Customs Commissionerate, Chennai issued a Show Cause Notice (`SCN') dated 8 November 2021 to the Company seeking differential duty for the nine Bill of Entries filed during the period 11 July 2017 to 26 July 2017 under CTH 9027 instead of classifying under CTH 9018.

2.9 The Company responded to the said SCN vide letter dated 10 December 2021, wherein the Company submitted that pursuant to the aforesaid Customs audit, the Company had already 'paid the differential duty for the Bill of Entries filed under CTH 9027. These Bill of Entries also included the nine Bill of Entries for which the SCN was issued. The Company had also brought attention of the authorities to divergent decisions pronounced by various authorities for the classification of Glucometers under CTH 9018 vs 9027. Since the differential .duty was already paid alongwith interest on delayed payment of duty, the Additional Commissioner of Customs, Chennai dropped the SCH for demand of duty, interest and penalty vide order dated 23 March 2022. Therefore, it is affirmed that at present, the questions raised in the present application are not pending in the applicant's case before any officer of customs, the Appellate Tribunal, or any Court.

2.10 As regards applicability of proviso (b) to section 28(2) seeking to ascertain whether the questions raised in the application have already been decided by the Appellate Tribunal or any Court, it is submitted that the applicant has come across certain decisions that may be germane to the said question, which are referred to in this application. It is, therefore, submitted before the Authority to take cognizance of the said decision of the Hon'ble High Court in pronouncing his rulings or hold that the same are squarely applicable to this applicant in respect of the questions presented for advance rulings.

2.11 As per Rule 1 of the General Rules of Interpretation of the Customs Tariff Act (hereinafter GIR), it is pertinent to note that the classification of goods shall be governed by the following principle:

"The titles of Sections, Chapters and Sub-Chapters are provided for ease of reference only; for legal purposes, classification shall be determined according to the terms of the headings and any relative Section or Chapter Notes and, provided such headings or Notes do not otherwise require, according to the following provisions."

Considering the nature of the product under consideration - Glucometer, it is relevant to examine various headings of Chapter 90 of the Customs Tariff Act. Based on the internal records and analysis of the applicant, stand of the Customs authorities, including in respect of the applicant, and judicial pronouncements, the following two Tariff Heading of Chapter 90 merit consideration:

Chapter Heading Description
9018 Instruments And Appliances Used In Medical, Surgical, Dental Or Veterinary Sciences, Including Scientigraphic Apparatus, Other Electromedical Apparatus And Sight-Testing Instruments
9027 Instruments And Apparatus For Physical Or Chemical Analysis (For Example, Polarimeters, Refractometers, Spectrometers, Gas Or Smoke Analysis Apparatus); Instruments And Apparatus For Measuring Or Checking Viscosity, Porosity, Expansion, Surface Tension Or The Like; Instruments And Apparatus For Measuring Or Checking Quantities Of Heat, Sound Or Light (Including Exposure Meters); Microtomes

2.12 The relevant extract of entries from Chapter 90 relevant to determination the classification of gIucometer is reproduced below -

Chapter 90 - Optical, photographic, cinematographic, measuring, checking, precision, medical or surgical instruments and apparatus; parts and accessories thereof

9018 - Instruments and appliances used in medical, surgical, dental or veterinary sciences, including scientigraphic apparatus, other electromedical apparatus and sight-testing instruments

Tariff No Items Covered Unit Basic Rate
9018 90 - Other instruments appliances :
— Diagnostic instruments and apparatus :
   
9018 90 99 — Other u 10%*

9027 - Instruments and apparatus for physical or chemical analysis (for example, polarimeters, refractometers, spectrometers, gas or smoke analysis apparatus); instruments  and apparatus for measuring or checking viscosity, porosity, expansion, Surface tension or the like; instruments and apparatus for measuring or checking quantities of heat, sound or light (including exposure meters); microtomes

Tariff No Items Covered Unit Basic Rate
9027 89 - Other:    
9027 89 90 — Other u Free

*The effective rate in case of blood monitoring system is reduced to 5% as per entry 576 of Notification No. 50/2017 - Cus., dated 30 June 2017. The relevant extract of the said Notification is reproduced below-

S. No Chapter or Heading or subheading or tariff item Description of goods Standard rate Integrated Goods,- Services Tax Condition No.
(1) (2) (3) (4) (5) (6)
576. 90 or any other Chapter Blood Glucose Monitoring System (Glucometer) . and test strips 5% - -

2.13 In view of the above, prima facie, it appears that the instruments/ appliances, which are used in medical/ surgical sciences would merit classification under CTH 9018. Whereas, instruments/ apparatus, which are used for chemical and physical analysis would merit classification under CTH 9027. Admittedly, both the competing CTH would cover instruments and appliances. The significant difference being that if the instruments/appliances are meant for use in medical/surgical sciences, it would be classifiable under CTH 9018, whereas if they are meant for use for physical or chemical analysis, it would be classifiable under CTH 9027. The subtle difference being whether the instruments/appliances are used for chemical analysis or in medical /surgical sciences.

2.14 Recognizing that Glucometers alongwith lancets, lancing devices and test strips are used for performing chemical test on blood to assess the glucose level, they are essentially being used for chemical analysis. The fact that such a chemical test may be used for medical treatment of the concerned person may not be construed to mean that the instrument is being used in medical sciences.

2.15 This averment is also consistent with the reference to different instruments/appliances in the said two CTH. Therefore, on the plain reading of the said two competing entries, the applicant is of the opinion that glucometers that are used by persons, not necessarily being a medical practitioner or associated with medical sciences, for simple chemical analysis of blood sample to test glucose levels contained therein, merit classification under CTH 9027.

2.16 However, it is submitted that to determine the appropriate classification of a good, reliance should also be placed on World Customs Organization (WCO) Harmonized System of Nomenclature (HSN), judicial pronouncements as well as advance rulings, if any in other jurisdictions, if any is available. The relevant extracts of the HSN are reproduced below:

90.18 - Instruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electro-medical apparatus and sight-testing instruments (+).

- Electro-diagnostic apparatus (including apparatus for functional exploratory examination or for checking physiological parameters):
9018.11 - - Electro-cardiographs
9018.12 - - Ultrasonic scanning apparatus
9018. 13 - - Magnetic resonance imaging apparatus
9018.14 - - Scintigraphic apparatus
9018.19 - - Other
9018.20 - Ultra-violet or infra-red ray apparatus
            - Syringes, needles, catheters, cannulae and the like :
9018.31 - - Syringes, with or without needles
9018.32 - - Tubular metal needles and needles for sutures 39 -
9018.39- Other
            - Other instruments and appliances, used in dental sciences :
9018.41 - - Dental drill engines, whether or not combined on a single base with dental equipment
9018.49 - - Other
 9018.50 - Other ophthalmic instruments and appliances 90 - Other instruments and appliances

This heading covers a very wide range of instruments and appliances which, in the vast majority of cases, are used only in professional practice (e.g., by doctors, surgeons, dentists, veterinary surgeons, midwives), either to make a diagnosis, to prevent or treat an illness or to operate, etc.

90.27 - Instruments and apparatus for physical or chemical analysis (for example, polarimeters, refractometers, spectrometers, gas or smoke analysis apparatus); instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like; instruments and apparatus for measuring or checking quantities of heat, sound or light (including exposuremeters); microtomes.

9027.10 - Gas or smoke analysis apparatus
9027.20 - Chromatographs and electrophoresis instruments
9027.30 - Spectrometers, spectrophotometers and spectrographs using optical radiations (UV: visible, IR)
9027.50 - Other instruments and apparatus using optical radiations (UV, visible, IR)
            - Other instruments and apparatus:
9027.81 - - Mass spectrometers
9027.89--Other
9027.90 - Microtomes; parts and accessories

2.17   On perusal of said Notes for Tariff heading 9018, it appears that the scope of the said heading is limited to instruments and appliances, which are used only in professional practice i.e. by doctors, surgeons, dentist, veterinary surgeons, etc. Further, it contains an illustrative list of all the products falling under the Tariff heading 9018 . Clause (q) of the exclusion list specified in the aforesaid explanatory note explicitly state "Instruments and appliances used in laboratories to test blood, tissue fluids, urine, etc., whether or not such tests serve in diagnosis (generally heading 90.27)." The said Notes for Tariff heading 9027 provides that the heading covers the instruments and apparatus which are used for physical and, chemical analysis. Therefore, reliance of HSN Explanatory Notes appear to support our initial averment that Glucometers are correctly classifiable under CTH 9027 and not CTH 9018.

2.18 Thereafter, we refer to judicial pronouncements relating to classification of glucometers. In the case of Bayer Pharmaceuticals Pvt. Ltd. 2016 (331) E.L.T. 317 (Tri. - Mumbai), it was held that Glucometers (with or without strips) should be classified under heading 9027, which covers instruments used for chemical analysis. Further, in the case of Ascensia Diabetes Care India Pvt. Ltd. (2023) 3 Centax 248 (Bom.), the Hon'ble Bombay High Court held that the Glucometer package i.e., Glucometer, strips, lancet device is classifiable under heading 9027. Similar view was adopted in the case of M/S. Sandor Medicaids 2023 (3) TMI 593 - CESTAT HYDERABAD, wherein while determining the classification of I state blood gas analyzer, it was observed that it is similar to Glucometer with only difference is that it is more sophisticated than Glucometer and held that the same should be classified under 9027.

2.19 The importer further submitted that they have not been able to find any order of High Court or CESTAT that has held instruments/appliances such as glucometer to be classifiable under CTH 9018. It is also submitted that the impugned SCH issued by the Additional Commissioner of Customs, Chennai had also not relied upon any judicial decision support of their averment that the glucometers merit classification under CTH 9018.

2.20 Therefore, we submit that the judicial precedence that we have been able to locate also appear to suggest that glucometers are correctly classifiable under CTH 9027. We, however, readily admit that it is understood that certain Customs adjudication authorities have issued adjudication orders classifying glucometers under CTH 9018, even as we understand that certain other Customs Authorities have held the same to be classifiable under CTH 9027.

2.21 Thereafter, reference is made to certain other key international pronouncements, including the US CROSS rulings. National Commodity Specialist Division (USA) in the case of Omnis Health, LLC [CROSS Ruling N027180 dated May 7, 2008], the authority ruled that the blood glucose monitoring system alongwith test strips are classifiable under the heading 9027. We have re-produced below the relevant extract of the ruling passed while analyzing the tariff classification of a blood glucose monitoring system along with test strips imported from Taiwan -

"You propose classification in HTSUS 9018.90. However, the Harmonized System Explanatory Note to its 9018 states:

The heading does not cover:

(Q) Instruments and appliances used in laboratories to test blood, tissue fluids, urine, etc., whether or not such tests serve in diagnosis (generally heading 90.27).

From your description, we take it that the monitoring system box will be packaged for retail sale with the smaller box of 50 test strips. We consider that to be a set in which the glucose meter supplies its essential character.

The applicable subheading for your blood glucose monitoring system along with test strips will be 9027.80.4530. Harmonized Tariff Schedule of the United States (HTSUS), which provides for Other, electrical, non optical instruments and appliances for chemical analysis. The rate of duty will be free."

2.22 In the recent ruling pronounced by the National Commodity Specialist Division (USA) in the case of Roche Diabetes Care Inc. [CROSS Ruling N332391], the authority ruled that the Glucose monitoring system which contains the Glucometer. test strip, a control solution bottle, batteries, lancing device imported from India is classifiable under the heading 9027. In view of the above, it appears that glucometers have been held to be classifiable under CTH 9027 by other reputed authorities, who rely of the HSN-based Customs classification.

2.23 Assuming that the glucometers are classifiable under CTH 9027 at the four-digit level, it is observed that the same would fall under the residual category i.e., Tariff Item 9027 89 90 at the eight-digit level.

2.24 As regards, the applicable rate of Basic Custom Duty, the importer has submitted that the rate of Basic Custom duty for the Tariff item 9027 89 90 is "Free" i.e. Nil whereas the entry 576 of Notification No. 50/2017 - Cus., dated 30 June 2017 provides the rate explicitly for "Glucometers:' as 5%.

2.25 Although the exemption notifications are issued to provide benefit to taxpayers in the form of complete exemption or concessional rate of duty, however it is not explicitly mandated under the Customs law that the exemption entry would supersede the tariff entry rate even though the original tariff rate is lower.

2.26 It is a settled principle of law that in case of two beneficial provisions existing in the law, the assessee can opt either of the two which is more beneficial. We have placed our reliance on Share Medical Care Vs Union of India [2007 (209) E.L.T. 321 (S.C.)]. We have re-produced below the relevant extract for reference -

"In the instant case, the ground which weighed with the Deputy Director General (Medical), DGHS for non-considering the prayer of the appellant was that earlier, exemption was sought under category 2 of exemption notification, not under category 3 of exemption notification and exemption under category 2 was withdrawn. This is hardly a ground sustainable in law. On the contrary, well settled law is that in case the applicant is entitled to benefit under two different Notifications or under two different Heads, he can claim more benefit and it is the duty of the authorities to grant such benefits if the applicant is otherwise entitled to such benefit. Therefore, non-consideration on the part of the Deputy Director General (Medical),DGHS to the prayer of the appellant in claiming exemption under category 3 of the notification is illegal and improper "

In the case of Commissioner of Customs (Port), Kolkata Vs Uma Export Ltd [(2024) 14 Centax 226 (Tri.-Cal)], the CESTAT held that -

"In the present case, we observe that during the period 23-12-2017 to 28-2-2018, the goods in question Peas [Pisum Sativum] was present both in SI No. 20 and SI No. 20A of the basic Notification No. 50/2017 Cus dated 30-6-2017 till the amendment Vide Notification No. 29/2018 Cus dated 1-3-2018 was carried out. Applying the case laws cited supra, the importers would be eligible to claim NIL rated BCD and file the consequent Refund claim. Accordingly, we hold that the importers have correctly sought Refund claim on the ground that they were not required to pay 50% BCD in the first place."

2.27 In light of the above discussion, we believe that since there are two provisions existing in the Customs law for the effective rate of duty i.e. "Nil"/ "Free" as per Tariff entry and "5%" as per the aforesaid Notification, we could opt for the beneficial provision i.e. Nil/ Free rate of Basic Custom Duty.

2.28 In view of the above submissions, the Company submitted that Glucometers being an instrument for chemical analysis would get classified under Tariff Item "9027 89 90" of Chapter 90 of the First Schedule to the Customs Tariff Act. The effective rate of Basic Custom Duty applicable is "Nil" as per the Tariff item 9027 89 90.

2.29 The applicant in his submission further stated that Glucometers being an instrument for chemical analysis would get classified under Tariff Item "9027 89 90" of Chapter 90 of the First Schedule to the Customs Tariff Act. The effective rate of Basic Custom Duty applicable is "Nil" as per the Tariff item 9027 89 90. We appreciate that the ruling of your authority would have prospective effect and under no circumstances will have any impact on past transactions/ cases. We confirm that if your authority passes ruling that Glucometers merits classification under Tariff Item "9027 89 90" with Nil rate of customs duty, Company will not approach Department for any refund or contest the past classification adopted at the self-assessment stages. Further, noting that the comments of the concerned Commissioner of Customs have not been received and it may be considered appropriate to provide another opportunity to present their contra opinion, if any, the Company requests for another opportunity for in person hearing before your Authority to reiterate our submissions and contest the contra views, if any.

3. The personal hearing in the matter was conducted on 13.11.2024 in the office of CAAR, Mumbai. During the personal hearing the authorised representatives of M/s. Roche Diabetes Care India Pvt Ltd., Shri V.S. Chauhan, Ms Apurva Sheth, Shri Deepak Sawant, Ms Ruchita Parsarampuria appeared online for the personal hearing on behalf of the applicant. They reiterated their submission filed with the application. They submitted that the proposed import goods is Glucometer:- Accu-Chek. The said device is primarily used for measuring blood sugar in human body. They contended that the subject goods may attract two competing heading i.e. 9018 and 9027 but their product merit classification under CTI 90278990. They relied upon the Mumbai High in BAYER case and other cases which is submitted with the application. They also reliled upon US Cross ruling N027180. They also referred the technical literature and HSN. They argued that the product of CTH 9027 can be administered without specialist while the product of CTH 9018 requires chemical and laboratory assistance and with an expert medical professional. Nobody appeared the hearing from the department side nor comments or submission have been given by the Jurisdictional commissioner of Customs, in respect of the subject application.

4. I have taken into consideration all the materials placed before me in respect of the subject goods including all the submissions and citations made by the applicant during the personal hearing. Accordingly, I proceed to pronounce a ruling on the basis of information available on record as well as existing legal framework having bearing on the classification of the goods in question under the first schedule of the Customs Tariff Act, 1975, specifically Chapter 90, its corresponding Chapter notes, supplementary notes and relevant HSN explanatory notes.

4.1 The first question requires ruling on classification of the goods i.e Glucometer to be imported. At the outset, we find that the issue raised in the first question is squarely covered under Section 28H(2)(a) of the Customs Act, 1962 being a matter related to classification of goods under the provisions of this Act.

4.2 To determine the correct tariff classification for blood glucose monitoring systems (referred to as `Glucometer’ in common parlance), it’s important to first identify the specific nature and function of the product. The nature of a blood glucose monitoring system refers to the essential characteristics and qualities that define its function, design, and purpose. These systems are specifically created to help individuals, especially those with diabetes, monitor their blood glucose levels regularly. The functions of a blood glucose monitoring system are aimed at providing accurate, rea -time data about blood glucose levels, helping individuals with diabetes manage their condition, track trends, and make informed decisions regarding their treatment an lifestyle. These devices are an essential tool not only for the people needing regular glucose testing but at the same time, it is equally beneficial to diagnose the blood glucose level and is reliable for daily self monitoring thereof.

4.3 Glucometer is a widely recognized portable device that allows individuals to measure their blood glucose levels easily and conveniently at home. It is designed for self-monitoring of blood glucose levels, primarily catering to individuals with diabetes or those at risk of developing diabetes. They provide an easy, convenient, and quick way for patients to track their blood sugar levels at home without the need for professional medical intervention.

4.4 It measures the concentration of glucose in a small blood sample, typically obtained by a finger prick using a lancet. The blood is then placed onto a test strip inserted into the device. These strips contain a glucose-specific enzyme, usually glucose oxidase, which reacts with the glucose in the blood. This chemical reaction produces an electrical signal, which the glucometer then reads and converts into a numerical value representing the blood glucose level. Most glucometers use electrochemical technology to measure glucose levels. The blood sample interacts with the test strip, and the glucose enzyme catalyzes a reaction that generates an electric current. The glucometer detects this current and, based on its strength, measures the electrical signal generated by this reaction and converts it into a digital reading which determines the amount of glucose in the blood sample, providing the user with an accurate blood glucose level in just a few seconds.

4.5 It is observed that the device Glucometer is primarily covered under Chapter 90 of the Indian Customs Tariff which deals with “Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus”, and glucometers, being medical diagnostic devices, falls under this category. Now the question arises whether the Glucometer is classified under Customs Tariff Heading 9018 or 9027.

4.6 The General Rules for the Interpretation of the Harmonized System (GIRs) are crucial in determining the correct classification. When it comes to classifying glucometers under heading 9018, the principle of “general versus specific” classification, primarily guided by GIR 3(a), is particularly relevant. GIR 3(a) states: “The heading which provides the most specific description shall be preferred to headings providing a more general description.” This rule is the cornerstone for classifying glucometers under 9018. Glucometers are designed and used for a specific medical purpose: monitoring blood glucose levels in patients. The argument for classifying glucometers under 9018 rests on the fact that they are specifically designed and used as medical devices for patient care, making 9018 a more specific and accurate classification.

4.7 In the case of a glucometer, the device is used for measuring blood glucose levels. This device, regardless of whether it is used by a healthcare professional or a diabetic patient, is classified based on its intended purpose and its functionality as a medical instrument. The glucometer does not change its nature based on the user. It is a medical diagnostic instrument used to monitor glucose levels, and its classification will depend on these functional characteristics, not the user. The classification of the glucometer remains fixed as a medical device, irrespective of who is operating it. As per the World Customs Organization (WCO) guidelines, classification is based on the good’s nature and function, not the user. A glucometer, being classified as a medical device, remains so regardless of whether it is used by a medical professional or a consumer.

4.8 A glucometer, also known as a blood glucose meter, is a medical device used to determine the approximate concentration of glucose in blood. It’s a key tool for people with diabetes to monitor their blood sugar levels. Glucometers are explicitly designed for medical purposes. They are essential for diagnosing, monitoring and managing diabetes, a critical medical condition. Glucometers are used directly by patients or by healthcare professionals for patient care, enabling timely supervision and adjustments in the treatment plans.

4.9 Diagnostic kits are generally defined as medical devices or in vitro diagnostic devices (IVDs) that are used to detect or diagnose diseases, conditions, or infections. These kits are used in laboratories, medical settings, or even at home, and their regulation varies depending on the jurisdiction. Below are some typical legal definitions and considerations for diagnostic kits, with a focus on regulatory frameworks

4.10 United States (FDA): In the United States, diagnostic kits are regulated Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic the Medical Device Amendments of 1976. The FDA defines In Vitro diagnostic (IVD) Device’s as reagents, instruments, and systems intended for use in the diagnosis of diseases or other conditions in humans. IVDs include diagnostic kits that are used to detect diseases, conditions, or infections by examining samples such as blood, urine, or saliva.

4.11 European Union (EU) : In the European Union, diagnostic kits are governed by the In Vitro Diagnostic Medical Devices Regulation (IVDR 2017/746), which came into effect in May 2022. The EU defines in vitro diagnostic medical devices as reagents, instruments, or systems intended to be used for the examination of specimens (e.g., blood, urine, or tissue) taken from the human body to provide information about a person’s health status or the presence of disease or infection.

4.12 World Health Organization (WHO) also provides guidelines and standards for diagnostic kits, particularly in the context of global health emergencies. The WHO’s guidelines define diagnostic kits as tools that are used to detect, monitor, or manage infectious diseases and other medical conditions, especially in resource-limited settings.

4.13 National Cancer Institute (NCI) :”A diagnostic test is a medical test that is performed help figure out what disease or condition a person has based on their signs and symptoms” Advin Healthcare:  “Diagnostic Kits - A  collection of the pre- — A collection of pre-packaged components used to perform a specific medical test to aid in the diagnosis or conditions..CD BioSciences: “Diagnostic Kite A pre-packaged collection of  reagents and other necessary items used to conduct a specific medical test to detect the presence of or to measure the levels of a given biomarker.”

4.14 From the above facts, I observe that Diagnostic kits are typically defined as medical devices or in vitro diagnostic devices (IVDs) intended to detect or diagnose diseases or medical conditions by analyzing samples from the human body. They are essential tools in modern healthcare, facilitating accurate and timely medical assessments. Their precise definition may vary slightly depending on the context, but the core concept remains consistent: a pre-packaged collection of components designed to perform a specific medical test for diagnostic or related purposes. The play a crucial role in identifying diseases, monitoring health conditions, and guiding treatment decisions. The primary function of these kits is diagnostic. They enable the detection of specific substances, pathogens, or conditions in a biological sample.

4-15 A glucometer, while often used for monitoring, also plays a crucial role as a diagnostic tool, particularly in the initial detection of diabetes and in assessing the need for further diagnostic tests. The U.S. Food and Drug Administration (FDA) classifies blood glucose meters (glucometers) as Class II medical devices. These devices are intended diagnostic purpose of measuring the concentration of glucose in the blood to monitor and manage diabetes, which is essential for diagnosing and tracking the disease. According to various literature, glucometers are used to diagnose the presence of abnormal blood glucose levels, which is a diagnostic indication for diabetes and pre-diabetes. In this case, they help in diagnostic decision-making by providing immediate glucose readings. This makes glucometers part of diagnostic tools in clinical settings, particularly in ambulatory or home healthcare. As per the American Diabetes Association (ADA) Blood glucose meters and testing strips are essential diagnostic tools for both diagnosing and managing diabetes and other blood sugar-related conditions. Glucometers are commonly used in home healthcare and point-of-care testing environments, where they assist patients and healthcare providers in diagnosing and monitoring diabetes. In some cases, glucometers are part of larger diagnostic systems designed to measure various health metrics. American Association for Clinical Chemistry (AACC) states that Glucometers are often considered diagnostic tools in point-of-care settings, providing critical glucose readings for diagnostic decision-making. In various international contexts, glucometers are referred to as part of diagnostic kits for managing conditions such as diabetes. For example, the World Health Organization (WHO) mentions the usage of glucometers in diagnosing conditions related to blood sugar regulation. It further states that devices such as Glucometers form part of diagnostic kits used to monitor glucose levels for both diagnostic and therapeutic purposes in patients with diabetes.

4.16 Therefore, I find that while glucometers are primarily used as medical devices for managing diabetes, they do play a role in diagnosing conditions related to blood glucose, and thus, can be categorized under diagnostic kits in certain contexts, especially in home or point-of-care testing settings.

4.17 An electro-medical apparatus refers to a medical device that uses electrical technology to measure the concentration of glucose in a person’s blood. A glucometer typically works by utilizing an electrochemical reaction on a test strip, where a small blood sample is applied. This reaction generates an electrical signal that the glucometer measures; which is then converted into a numerical reading that indicates the blood glucose level. Thus, I conclude that the glucometer is considered an electro-medical apparatus because it uses electrical signals and principles in its diagnostic function to monitor and manage diabetes.

4.18 Further, the use of a glucometer involves more than just pressing a button or inserting a test strip — it requires knowledge of proper techniques, understanding of the device’s features, and the ability to interpret the results accurately. A glucometer typically consists of several components. Proper knowledge of how each of these components works is crucial for accurate testing. A person must understand how to properly insert and dispose of test strips, how to change the battery of the meter, and how to safely dispose of lancets to avoid contamination and injury. Without this basic knowledge, a user may either harm themselves or get incorrect readings, undermining the effectiveness of the device. It involves technical skills, knowledge of the device, understanding how to collect and handle blood samples, interpreting the results accurately, and maintaining proper hygiene and safety protocols. The consequences of improper use can include inaccurate readings, delayed medical intervention, or health risks such as hypoglycemia or hyperglycemia.

4.18.1 As submitted by the applicant, the user manual is a comprehensive guide that includes instructions on how to properly use the glucometer. It provides essential guidelines for the device’s setup, usage, maintenance, and interpretation of results. This manual covers

  • How to set up the device: Unboxing and assembling parts, inserting batteries, or connecting with smartphones if necessary.

  • How to perform a blood test: Step-by-step instructions on preparing the test strip, using the lancet for a blood sample, and reading the results.

  • Device maintenance: Information on ‘cleaning, storing, and maintaining the gluecometer for proper functionality.

  • Safety and handling instructions: Warnings about potential hazards, such as using t e device improperly or using expired test strips.

The user manual stresses the importance of Following each step in the user manual to ensure the glucometer functions correctly. If not used as instructed, there are several risks:

  • lnaccurate readings: If the device is not calibrated or used incorrectly, it could give false results, leading to incorrect decisions about health care management.

  • Device malfunction: Improper handling (e.g., incorrect insertion of test strips, failure to clean the device) could damage the glucometer, making it unreliable or causing it to stop working altogether.

  • Health risks: Incorrect blood sample size, handling of test strips, or improper disposal of lancets can also pose health risks, such as infection or incorrect treatment of blood sugar levels

The Users must possess a fundamental understanding of how to operate the glucometer safely and effectively. This includes knowing how to correctly apply test strips, collect a proper blood sample, and accurately interpet the reading displayed on device collection of blood collection of samples, Without sufficient knowledge, there is always a risk of improper Mood collection of samples, testing thereof and misinterpretation of results pertaining to blood glucose levels or that of mishandling equipment such as lancets and srips which may lead to user manual, as it contains vital instructions for the safe and proper use of the Accu-Chek glucometer. Thus, it can be understood that, following the proper instructions is essential to obtain a correct reading/ outcome and failing which the consequent health risks is inevitable. For this reason, it is imperative that users should be able to fully read and comprehend the manual before using the device.

4.18.2 Further, the user manual available online on the website for the Accu-Chek devices are provided largely in English language. The manual contains a significant amount of scientific and technical terminology, which may not be easily understood by all users. In India, literacy, especially proficiency in English language appears significantly lower. Given these factors, the instructions provided in the user manual are likely to be difficult for a large segment of the population to comprehend in their entirety. Therefore, proper training is essential to ensure that glucometer users, whether patients is or healthcare providers, are using the device correctly and managing their health effectively. It is thus clear that a glucometer requires, both technical skill and knowledge to be used safely and effectively. To ensure accurate results and proper management of conditions like diabetes, training — often provided by healthcare professionals - is necessary to complement the instructions in the manual. So the contention of the applicant that Glucomters in vast majority of the cases are used by the individuals at home i.e. by the common untrained persons appears contradictory.

4.18.3 Moreover, as per the Accu-Chek user manual heading “intended use”, the blood glucose monitoring system comprises the meter and test/ strips and is suitable for self-esteem and for professional use. People with diabetes can use this system to self-test their blood glucose. Healthcare professionals can use this system to measure the patient’s blood glucose values and they can use it in suspected cases of diabetes, in emergency diagnostics. Thus, as per user’s manual these devices can be used both by a healthcare professional and by a diabetic person. Hence, in view of the above, there cannot be two different classification of the subject goods i.e. glucometers when used one by a healthcare professional and another when used by the untrained/ diabetic person for identical usage.

4.19 The Explanatory Notes define the scope of each HS heading, detailing the types of goods that are included and excluded. They clarify the meaning of terms used in the HS and offer practical guidance on classifying goods based on their characteristics, properties, and intended use. They help to resolve ambiguities and inconsistencies that may arise during the classification process.

4.20 As per the Explanatory notes, HSN Code 9018 covers instruments and apparatus used in medical, surgical, or veterinary sciences, including scientigraphic apparatus, other electromedical apparatus and sight-testing instruments. This heading covers a very wide range of instruments and appliances which, in the vast majority of cases, are used only in professional practice (e.g., by doctors, surgeons, dentists, veterinary surgeons, midwives), either to make a diagnosis, to prevent or treat an illness or to operate, etc. Further, para (V) of the Explanatory Notes to the Harmonized System (HS) Code 9018 clearly states that the heading 9018 covers electro-medical apparatus for preventive, curative or diagnostic purposes, other than X-ray, etc, apparatus of heading 9022. It includes devices used for diagnosing medical conditions. Glucometers often fall under this heading because Glucometers are primarily used to measure glucose levels in the blood, and they serve a diagnostic function, which is why they are classified as in vitro diagnostic devices (IVDs) in many regulatory frameworks. Despite using electrochemical technology (which differs from some purely electrical diagnostic methods like ECGs or EEGs), glucometers still rely on electrical circuits or sensors to provide a result. The device’s use of electrical components to detect glucose levels aligns it with the broad category of “electro-medical apparatus” in HSN Heading 9018.

4.21 While there might be other potential classifications, they don’t accurately capture the primary function and purpose of a glucometer. For instance, heading 9027, which covers instruments for physical or chemical analysis, might ‘seem relevant. However, glucometer, an electro-medical apparatus is specifically designed as a medical instrument/apparatus for patient care, making 9018 the more appropriate classification Based on its medical purpose, diagnostic function, and role in patient care, the glucometer is appropriately classified under Customs Tariff Heading 9018.

4.22 I observe that the Hon’ble Supreme Court in the case of Commissioner of Central Excise Vs. Wockhardt Life Sciences Ltd reported in 2012 (277) ELT 299 (SC) had held that he functional utility and predominant usage of the commodity must be taken into ,account apart from the understanding in common parlance to determine the correct classification of the product. The Hon’ble Supreme Court in the case of Collector of Costoms Vs. Kumudam Publications [1997 (96) ELT 226 (SC)] has held that “it is not entirely correct to say that the end use or function of the goods is irrelevant to decide the question of classification”. A three Judge Bench of the Hon’ble Supreme Court had also relied upon the function and end use in determining the classification in the case of indian Tool Manufactures Vs. Asst. Collector of Central Excise, Nasik & Others report d in 1994 (74) ELT 12 (SC).

4.23 In an identical matter, the issue of classification of Glucometers was considered by the Authority for Advance Ruling under GST, Haryana. In the Ruling No. 2021 (48) G.S.T.L. 393 (A.A.R. - GST - Haryana) in the matter of SOURCE OF LIFE TECHNOLOGIES (INDIA) PVT. LTD., the Hon’ble Authority has ruled that Glucometer is used to measure blood glucose and hence classifiable under Heading 9018 of Customs Tariff Act, 1975.

4.24 The case laws relied upon by the applicant are not squarely applicable to this case

4.25 Further to understand the 8-digit classification of Glucometers, let’s break it down step by step.

(i) Chapte Level (First 2 Digits): 90

This indicates that the product belongs to Chapter 90 of the Harmonized System (HS) Code. Chapter 90 covers “Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus”. It covers a wide range of medical instruments and devices. As Glucometers are primarily used as medical devices for managing diabetes they fall under this category.

(ii) Heading Level (Next 2 Digits): 18

This further specifies the type of instrument or appliance within Chapter 90. Heading 9018 covers ‘Instruments and appliances used in medical, surgical, dental or veterinary science, including scientigraphic apparatus, electromedical apparatus and similar apparatus; parts and accessories thereof.” It covers a broad range of medical and surgical instruments, including those used for diagnosis and treatment. Since Glucometers is used to monitor glucose levels for both diagnostic and therapeutic purposes in patients with diabetes, it falls under this category.

(iii) Subheading Level (Next 2 Digits): 19

This level provided a more detailed classification within Heading 9018. Subheading 9018 19 specifically refers to “Other instruments and apparatus” within the electro-medical apparatus category, including those used for diagnostic purposes in the case of a glucometer, it uses an electrochemical reaction to produce an electrical signal when blood glucose interacts with the test strip. This signal is then converted into a readable value indicating blood glucose concentration. So, glucometers fit into HS code 9018 19 as they rely on electrochemical principles to measure a physical quantity (blood glucose), making them part of the category of electro-medical apparatus.

(iv) Specific Classification Level (Last 2 Digits): 90

This final level provides the most specific classification for Glucometers within Subheading 9018 19. The classification 9018 19 90 further specifies the classification as “other” medical instruments and devices that don’t fall under more specific sub categories within 9018. Since glucometers are not specifically listed under a separate subheading for medical diagnostic equipment, they fall under the residual category within the broader classification of HSN 9018 19 90. They function as electro-medical apparatus because they use electrical principles (electrochemical reactions) to deliver diagnostic results.

5. In view of the above facts, I find that Glucometers, being precise devices for managing diabetes, are considered specialized medical appliances used for measuring blood glucose levels. Although glucometers are not specifically mentioned as other types of electro-medical devices, they are considered part of this broader category because they are undisputedly medical devices and are used for diagnosis (measuring glucose levels in blood) and they are operated based on electrical principles (through electrochemical sensors).

5.1 In light of the aforementioned. Facts, observations and discussions made I am of the considered view that the appropriate eight-digit classification for glucometers is 9018 19 90 - ‘Other Electro-Medical Apparatus.

5.2 The next question requires ruling on the rate of duty applicable on the import of Glucometers. To determine the exact rate of duty applicable to goods imported into India, we need to know its specific classification under the Harmonized System (HS) code. As discussed above, I am of the view that the Glucometers are appropriately classifiable under HS Code 9018 19 90. Customs Tariff Act, 1975 specifies duty rates for different goods under the Harmonized System (HS) code classification. General Rates are the rates that apply to products classified under a particular tariff heading. Specific Rates are rates that apply to specific products or categories, often outlined in notifications or orders. The CBIC issues periodic notifications that may alter or amend the applicable duty rates on certain goods. These notifications can provide specific exemptions, reductions, or additional tariffs for certain items. Accordingly, I find that the applicable rate of duty for glucometers will ultimately depend on the rates specified in the relevant tariff heading in the Customs Tariff Act, 1975, as well as any import notifications issued by the Central Board of Indirect Taxes and Customs (CBIC) from time to time.

6. On the basis of my foregoing discussions and findings, the ruling so sought in the present advance ruling application is accordingly answered as under: -

Question 1: Whether the “Accu-Chek” blood glucose monitoring systems (commonly referred to as “Glucometer”) imported by the Applicant is classifiable under Customs Tariff Heading (`CTH’) - 9027 of Chapter 90 of the First Schedule to the Customs Tariff Act,1975 (`Customs Tariff Act)?

Ans. No. The Accu-Chek blood glucose monitoring systems (commonly referred to as glucometers) are appropriately classifiable as an electro-medical apparatus under instruments/ apparatus used in medical sciences under Customs Tariff Heading (CTH) 9018 of Chapter.90 of the Customs Tariff Act, 1975.

Question 2: If the answer to the above question is affirmative, whether the Glucometer is classifiable under the Tariffw Item 9027 89 90 under CTH 9027 of Chapter 90 of the First Schedule to the Customs Tariff Act?

Ans. Not applicable

c. Question 3: If the answer to the above question is positive, then whether the effective rate of duty will be “Nil” as per the Customs Tariff entry?

Ans. Not applicable.

d. Question 4: If the answer to the above questions is negative, then what would be the correct classification of Glucometer under the Customs Tariff Act?

Ans. Glucometers are appropriately classifiable under HS Code 9018 19 90.

I rule accordingly.

(PRABHAT K RAMESHWARAM)
Customs Authority for Advance Ruling,
Mumbai.                         

 

F. No. CAAR/CUS/APPL/191/2024-O/o Commr-CAAR-Mumbai    Dated: 02.01.2025

This copy is certified to be a true copy of the ruling and is sent to:

1. M/s Roche Diabetes Care India Pvt. Ltd
146-B, 166A, Unit No. 7, 8, 9, 8- floor,
R City Office, R City Mall, LBS Marg,
Ghatkopar Mumbai 400 086

2. The Principal Commissioner of Customs,
Air Cargo, New Custom House,
Chennai-VII Commissionerate,
Air Cargo Complex, Meenarnbakkam, Chennai 600 027.

3. The Customs Authority for Advance Rulings,
Room No. 24, New Customs House,
Near IGI Airport, New Delhi-110037. Email: cus-advrulings.del@gov.in

4. The Principal Chief Commissioner of Customs,
Mumbai Customs Zone-I, Ballard Estate,
Mumbai -400001.
Email: ccu-cusmum1@nic.in

5. The Commissioner (Legal), CBIC Offices,
Legal/CX.8A, Cell, 5- floor, Hudco Vishala Building,
C-Wing, Bhikaji Cama Place, R. K. Puram, New Delhi - 110066.
Email: anishqupta.irs@gov.in, commr.leqal-cbec@nic.in

6. The Member (Customs), Central Boards of Indirect Taxes & Customs,
North Block, New Delhi-110001.
Email: mem.cus-cbec@nic.in


7. The Webmaster, Central Boards of Indirect Taxes
& Customs.
Email: webmaster.cbec@iceqate.gov.in

8. Guard file

(Vivek Dwivedi)                     
Deputy Commissioner & Secretary
Customs Authority for Advance Rulings.
Mumbai